UC Berkeley alumnus Gary Ruvkun has been awarded the 2024 Nobel Prize in Physiology or Medicine. Ruvkun, a 1973 graduate with a B.A. in biophysics, shares the prize with Victor Ambros, a professor at the UMass Chan Medical School, for their discovery of microRNA and and its role in post-transcriptional gene regulation. MicroRNA are tiny pieces of genetic information that play critical roles in helping cells regulate gene expression and control what types of proteins they produce.
The work from Ruvkun and Ambros has influenced scientists worldwide, guiding research for diseases such...
By digitally mapping the whole brain of a fruit fly, scientists hope to gain insight into human brain disorders.
As a large team of scientists recently completed the assembly of a complete wiring diagram of the adult fruit fly brain, Phil Shiu decided to simulate that massive circuit — 139,255 neurons and 50 million connections — in a computer.
That simulation, which can run on a laptop, proved amazingly good at predicting how the real fly brain responds to stimuli. In a paper published...
Chancellor Rich Lyons and Executive Vice Chancellor and Provost Ben Hermalin announced today that Interim Dean Richard Harland has been appointed as dean of the Division of Biological Sciences:
Dear Campus Community,
We are pleased to announce that Richard Harland has been selected to serve as dean of the College of Letters & Science Division of Biological Sciences at UC Berkeley. Professor Harland has been serving the university as interim dean since July 2024, senior associate dean since 2016, and professor of molecular and cellular biology...
Four decades after arriving at UC Berkeley as a new faculty member, Richard Harland remains fascinated by embryos, evolution, and early developmental biology. In his first public interview as dean, Harland explained why he came to Berkeley, what it takes to enable top-tier research, how the division serves the state, and what pulled him away from his beloved lab to take on a leadership role.
Fareed Zakaria GPS takes a comprehensive look at foreign affairs and global policies through in-depth, one-on-one interviews and fascinating roundtable discussions.
On the September 2, 2024 episode: Reengineering Life: The Next Frontiers in Science
Fareed examines two emerging technologies that are already changing life as we know it—CRISPR gene editing and artificial intelligence—in interviews with two women who pioneered them: UC Berkeley’s Jennifer Doudna and Stanford’s Fei-Fei Li.
When biochemist Jennifer Doudna and her research partner, Emmanuelle Charpentier, published a paper in Science 12 years ago, they had a hunch that their findings would transform how genomics is used in medicine. The paper outlined a method they’d developed for editing DNA that used an RNA-based system known as CRISPR-Cas9. The approach was more efficient and precise...
By Chancellor Carol T. Christ and Executive Vice Chancellor and Provost Benjamin E. Hermalin
The following message was shared with the UC Berkeley community on June 27, 2024.
Dear Colleagues,
The search for the next dean of the Division of Biological Sciences is ongoing; we remain optimistic that we will be able to share news regarding the dean search in the coming weeks. In the meantime, we are grateful to Senior Associate Dean Richard M. Harland, who has graciously agreed to step into the dean role on an interim basis effective July 1, 2024.
In an announcement today (Wednesday, June 12), the Norwegian Academy of Science and Letters named two University of California, Berkeley, faculty members — Doris Ying Tsao, professor of molecular and cell biology, and Armand Paul Alivisatos, professor emeritus of chemistry — winners of 2024 Kavli Prizes in the fields of neuroscience and nanoscience, respectively.
When biochemist Jennifer Doudna and her research partner, Emmanuelle Charpentier, published a paper in Science 12 years ago, they had a hunch that their findings would transform how genomics is used in medicine. The paper outlined a method they’d developed for editing DNA that used an RNA-based system known as CRISPR-Cas9. The approach was more efficient and precise...